Allogene Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0197701065

SecurityALLO / Allogene Therapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership262,695 shares
Latest Disclosed Value $ 296,845
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 25.28% increase in ownership of ALLO / Allogene Therapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 262,695 shares of Allogene Therapeutics, Inc. (US:ALLO) valued at $296,845 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 209,689 shares of Allogene Therapeutics, Inc.. This represents a change in shares of 25.28% during the quarter. The current value of the position is $493,867 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Allogene Therapeutics EC US0197701065 262,695 53,006 25.28 297 -3.27 0.0067
2025-05-28 2025-03-31 NP Allogene Therapeutics EC US0197701065 209,689 0 0.00 306 -31.39 0.0073
2025-02-25 2024-12-31 NP Allogene Therapeutics EC US0197701065 209,689 0 0.00 447 -24.02 0.0098
2024-11-26 2024-09-30 NP Allogene Therapeutics EC US0197701065 209,689 33,561 19.05 587 43.17 0.0111
2024-08-26 2024-06-30 NP Allogene Therapeutics EC US0197701065 176,128 29,218 19.89 410 -37.50 0.0084
2024-05-28 2024-03-31 NP Allogene Therapeutics EC US0197701065 146,910 0 0.00 657 39.28 0.0137
2024-02-26 2023-12-31 NP Allogene Therapeutics EC US0197701065 146,910 11,763 8.70 472 10.05 0.0101
2023-11-28 2023-09-30 NP Allogene Therapeutics EC US0197701065 135,147 -9,968 -6.87 428 -40.64 0.0112
2023-08-25 2023-06-30 NP Allogene Therapeutics EC US0197701065 145,115 19,380 15.41 721 16.10 0.0171
2023-05-26 2023-03-31 NP Allogene Therapeutics EC US0197701065 125,735 0 0.00 621 -21.39 0.0165
2023-02-24 2022-12-31 NP Allogene Therapeutics EC US0197701065 125,735 -482 -0.38 791 -42.04 0.0218
2022-11-25 2022-09-30 NP Allogene Therapeutics EC US0197701065 126,217 3,099 2.52 1,363 -2.85 0.0391
2022-08-25 2022-06-30 NP Allogene Therapeutics EC US0197701065 123,118 15,581 14.49 1,404 43.31 0.0388
2022-05-26 2022-03-31 NP Allogene Therapeutics EC US0197701065 107,537 4,425 4.29 980 -36.35 0.0228
2022-02-25 2021-12-31 NP Allogene Therapeutics EC US0197701065 103,112 0 0.00 1,538 -41.94 0.0334
2021-11-24 2021-09-30 NP Allogene Therapeutics EC US0197701065 103,112 0 0.00 2,650 -1.49 0.0584
2021-08-26 2021-06-30 NP Allogene Therapeutics EC US0197701065 103,112 21,027 25.62 2,689 -7.18 0.0577
2021-05-27 2021-03-31 NP Allogene Therapeutics EC US0197701065 82,085 -2,342 -2.77 2,898 36.01 0.0657
2021-02-25 2020-12-31 NP Allogene Therapeutics EC US0197701065 84,427 -3,702 -4.20 2,131 -35.90 0.0546
2020-11-25 2020-09-30 NP Allogene Therapeutics EC US0197701065 88,129 6,106 7.44 3,323 -5.38 0.1066
2020-08-27 2020-06-30 NP Allogene Therapeutics EC US0197701065 82,023 19,233 30.63 3,512 187.87 0.1148
2020-06-01 2020-03-31 NP Allogene Therapeutics EC US0197701065 62,790 2,675 4.45 1,221 -21.84 0.0499
2020-02-27 2019-12-31 NP Allogene Therapeutics EC 019770106 60,115 859 1.45 1,562 -3.34 0.0470
2019-11-27 2019-09-30 NP Allogene Therapeutics EC US0197701065 59,256 59,256 1,615 0.0534
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.